Ado-trastuzumab emtansine Intravenous and CRM
Determining the interaction of Ado-trastuzumab emtansine Intravenous and CRM and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: chromium picolinate
Brand name: Cr-GTF, CRM, Chromium GTF
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-CroFab
- Ado-trastuzumab emtansine Intravenous-Cromolyn
- Ado-trastuzumab emtansine Intravenous-Cromolyn (Oral Inhalation)
- Ado-trastuzumab emtansine Intravenous-Cromolyn (Systemic)
- Ado-trastuzumab emtansine Intravenous-Cromolyn Capsules
- Ado-trastuzumab emtansine Intravenous-Cromolyn Inhalation, oral/nebulization
- CRM-Adox Pak 2/100
- CRM-Adoxa
- CRM-Adoxa CK
- CRM-Adoxa Pak
- CRM-Adoxa Pak 1/100
- CRM-Adoxa Pak 1/150